Floatz logo

bdb001

Tumor, Solid

Eikon TherapeuticsPhase 2Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
81/ 100

Competitive context

927 Active assets in the Tumor, Solid cohort.

Asset / SponsorPhaseRating
PANITUMUMAB
Astellas Pharma Inc
Phase 2BBB
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM
Sanofi
Phase 4BB
Glycopyrrolate
Medical College of Wisconsin
Phase 4BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
LIDOCAINE
Medical College of Wisconsin
Phase 4BB

View all 50 →

Same molecule, other indications

bdb001 is also rated in:

melanomaDormant
B
Indicative ·
62 / 100
View asset →
anaplastic astrocytomaDormant
B
Indicative ·
57 / 100
View asset →
anaplastic oligoastrocytomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →